Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Markman

Showing results (141-150 of 545) with videos related to

Pageof 55
Sort By:
Minerva Ginecologica|June 10, 2011
Role of chemotherapy in epithelial ovarian cancerM Markman
Cancer Treatment Reviews|December 1, 1986
Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavityM Markman
Current Oncology Reports|December 21, 2000
"Clinical benefit" following treatment with antineoplastic drugs: what does it mean and how should we measure it?M Markman
The American Journal of the Medical Sciences|January 1, 1984
Mediastinal fibrosis simulating residual Hodgkin's diseaseM Markman
Cleveland Clinic Journal of Medicine|May 1, 1996
Shark cartilage: the Laetrile of the 1990sM Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
CA-125: an evolving role in the management of ovarian cancerM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Fourth biennial meeting of the International Gynecologic Cancer Society, Stockholm 1993M Markman
Seminars in Oncology|June 1, 1991
Intraperitoneal chemotherapyM Markman
JAMA|April 3, 1981
Falling hematocrit value on cessation of smokingM Markman
Oncology (Williston Park, N.Y.)|March 29, 2001
Is there a role for intraperitoneal chemotherapy in the management of ovarian cancer?M Markman
Pageof 55

Showing results (141-150 of 545) with videos related to

Sort By:
Pageof 55
Minerva Ginecologica|June 10, 2011
Role of chemotherapy in epithelial ovarian cancerM Markman
Cancer Treatment Reviews|December 1, 1986
Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavityM Markman
Current Oncology Reports|December 21, 2000
"Clinical benefit" following treatment with antineoplastic drugs: what does it mean and how should we measure it?M Markman
The American Journal of the Medical Sciences|January 1, 1984
Mediastinal fibrosis simulating residual Hodgkin's diseaseM Markman
Cleveland Clinic Journal of Medicine|May 1, 1996
Shark cartilage: the Laetrile of the 1990sM Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
CA-125: an evolving role in the management of ovarian cancerM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Fourth biennial meeting of the International Gynecologic Cancer Society, Stockholm 1993M Markman
Seminars in Oncology|June 1, 1991
Intraperitoneal chemotherapyM Markman
JAMA|April 3, 1981
Falling hematocrit value on cessation of smokingM Markman
Oncology (Williston Park, N.Y.)|March 29, 2001
Is there a role for intraperitoneal chemotherapy in the management of ovarian cancer?M Markman
Pageof 55